Vinge advises Calliditas Therapeutics, a specialty pharmaceutical company listed on Nasdaq Stockholm and on The Nasdaq Global Select Market in the US, in connection with a directed share issue whereby the company will raise proceeds of approximately SEK 324 million, before issue costs.
Surgical Science Sweden AB, listed on Nasdaq First North Growth Market, has performed a directed new issue of shares valued at approximately SEK 2.7 billion at a subscription price of SEK 210.
Vinge has advised VNV Ltd in connection with the process of changing the group’s domicile from Bermuda to Sweden (the “Redomestication”). The Redomestication is carried out by way of a scheme of arrangement under Bermuda law, whereby Swedish Depository Receipts in VEF Ltd are exchanged for shares in the Swedish group entity VEF AB (publ), which constitutes the new parent company of the group following the Redomestication. The shares of VEF AB (publ) is listed on Nasdaq First North Premier Growth Market.
Vinge advises Profoto Holding AB (publ) in connection with the listing on Nasdaq Stockholm. The prospectus was published on 21 June 2021 and the first day of trading on Nasdaq Stockholm was 1 July 2021. The offering price was SEK 66 per share, corresponding to a market value of approximately SEK 2,6 billion.
Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) has entered into an agreement to acquire 70 per cent of the shares in the property rental company Unobo AB from Riksbyggen.
Hanover Active Equity Fund II has announced a public offer to the shareholders of ZetaDisplay AB (publ). The total value of the offer is SEK 710 million.
Vinge together with Weil, Gotshal & Manges LLP is advising a consortium led by Advent International in connection with its acquisition of Hoist Group Holding Intressenter AB (publ) (the ”Hoist Group”).
HELLA GmbH & Co. KGaA, one of the largest manufacturers of radar in the automotive industry, has made an investment of MSEK 182.3 and entered into a licensing and development agreement with time limited exclusivity for corner and side radar with Gapwaves AB (publ).
Vinge has advised Isofol Medical AB (publ), Nasdaq First North Premier Growth Market, in connection with a fully guaranteed rights issue and exercised over-allotment option which together add SEK 500 million to Isofol before transaction costs.
Vinge has advised Sdiptech AB (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market. The prospectus was published on 8 June 2021 and the trading on Nasdaq Stockholm commenced on 11 June 2021.
Northvolt has carried out a USD 2.75 billion private placement to finance further battery cell production capacity and R&D efforts in order to meet the increasing demand of customers.
